Last $843.27 MXN
Change Today 0.00 / 0.00%
Volume 119.0
MRK* On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 4:09 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adam H. Schechter

Executive Vice President and President of Global Human Health, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
49$5,142,557
As of Fiscal Year 2013

Background*

Mr. Adam H. Schechter has been the President of Global Human Health and Executive Vice President at Merck & Co., Inc. since May 2010. Mr. Schechter served as President of Global Pharmaceuticals at Merck Frosst Canada Ltd., a subsidiary of Merck & Co. Inc. He served as the President of Global Pharmaceuticals of Merck & Co. Inc. since August 2007. He served as President of U.S. Human Health - commercial of Merck & Co. Inc. from July 2006 to August 2007. Mr. Schechter served ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

2013-Present
Director, Member of Compensation Committee and Member of Quality & Compliance Committee

Education*

BA 1986
La Salle University

Other Affiliations*

Annual Compensation*

Salary$957,306
Total Annual Compensation$957,306

Stock Options*

Restricted Stock Awards$1,813,702
All Other Compensation$160,359
Exercisable Options474,289
Exercisable Options Value$5,416,417
Unexercisable Options517,086
Unexercisable Options Value$4,408,811
Total Value of Options$9,825,228
Total Number of Options991,375

Total Compensation*

Total Annual Cash Compensation$1,808,852
Total Short Term Compensation$957,306
Other Long Term Compensation$1,974,061
Total Calculated Compensation$5,142,557
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK*:MM $843.27 MXN 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
€3.9M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.